"A novel regimen incorporating the concomitant administration of fludarabine and alemtuzumab for the treatment of refractory adult acute lymphoblastic leukaemia: a report of three cases." by Aric Parnes

Selected Works of Carlo B. Bifulco, M.D.

Article

A novel regimen incorporating the concomitant administration of fludarabine and alemtuzumab for the treatment of refractory adult acute lymphoblastic leukaemia: a report of three cases.

British Journal of Haematology (2007)

Aric Parnes, Yale University
Carlo Bifulco, Yale University
Gary J. Vanasse, Departments of Internal Medicine

Link

Disciplines

Medicine and Health Sciences,
Oncology and
Internal Medicine

Publication Date

October 1, 2007

DOI

10.1111/J.1365-2141.2007.06760.X

Citation Information

Aric Parnes, Carlo Bifulco and Gary J. Vanasse. "A novel regimen incorporating the concomitant administration of fludarabine and alemtuzumab for the treatment of refractory adult acute lymphoblastic leukaemia: a report of three cases." British Journal of Haematology Vol. 139 Iss. 1 (2007) p. 164 - 165
Available at: http://works.bepress.com/carlo-bifulco/136/